AKT1 and cancer: [31, 32]Increased LIPG expression was reported as a possible urinary cancer biomarker.[32] Studies described increased expression of secondary messenger molecules (DAPP, CREB3L2) in colon cancer with the growth and invasion of colon cancer cells via PI3K/AKT pathway activation.[33]